Vous recherchez un Doctorat d'Université. Vous êtes intéressés par #Pseudomonas aeruginosa et #épithelium respiratoire. Université de Reims Champagne-Ardenne notre équipe Inserm UMR-S 1250 propose un projet de 3 ans pleinement financé. Pour plus de détail 👇. N'hésitez pas à nous contacter.

You are looking for a PhD position. You are interested in #Pseudomonas aeruginosa and #respiratory epithelium. Université de Reims Champagne-Ardenne our team Inserm UMR-S 1250 offers a fully funded 3-year PhD position. For more details 👇. Please don't hesitate to contact us.

Excited to share our latest article published in @plospathogens: journals.plos.org/plospathogens/… #plospathogensauthor

Few month ago, I’ve joined PLOS Pathogens Board of Editors as an Academic Editor. Very proud to be part of it. Glad to participate in peer-reviewing for an open science. #pseudomonas #epithelium Inserm @InsermEst Université de Reims Champagne-Ardenne CHU de Reims

Tout est dit…

Promising WG

Great meeting for the #EURESTOP COST #CA21145. Plenty of 🇪🇺scientists here to tackle #AMR.

Pls RT: Open postdoc position with Alan R. Hauser Lab (Northwestern U, Chicago) studying pathogenesis/antibiotic resistance of Pseudomonas and Klebsiella. How do these nasty bugs cause infections and resist treatment? See labs.feinberg.northwestern.edu/hauser/ to apply.

Mission #ATS2023 #Infectiologie #readaptation #respiratoire Dégradation de la fonction respiratoire après une infection à VRS 👉tinyurl.com/2y3smb5w Réadaptation respiratoire post-exacerbation de BPCO 👉tinyurl.com/mpexfwx3 cphg AJPO2 - Jeunes Pneumologues CEPR_Pathophysiology_Respiratory_Infections @GroupeJ2r

Très intéressant. A lire…et à méditer.

👋 THREAD Rédiger une demande de financement en recherche biomédicale 💊🧪 Je vois passer des dossiers qui se tirent une balle dans le pied et ça me fait de la peine. Voici quelques conseils. Amicaux. 1/11

Maybe Acinetobacter baumannii?

Happy to share our new study Journal of CF 🦠#pseudomonas Airway infections as a risk factor for Pseudomonas aeruginosa acquisit... sciencedirect.com/science/articl… crsaparis Fondation pour la Recherche Médicale Vaincre la Muco #SAM2025 @HarrietCorvol Mesinele Julie @MedecineSU Inserm Île-de-France

🔴 #J2R 2023 Société de Pneumologie de Langue Française (SPLF)✨ Coup d'envoi des journées de #recherche 🔬respiratoire 🫁 au palais des Congrès de Ville de Tours ! Un concentré de chercheurs qui partagent leur innovation et découverte 💡 dans les #maladiesrespiratoires Merci 🙏 @GroupeJ2r #maladiesrares

FilmArray Pneumonia Plus BioFire Diagnostics (now bioMérieux) doesn't detect 2 K. aerogenes subspecies. Our paper from @InsermEst UMRS-1250 Bacterio@P3Cell Université de Reims Champagne-Ardenne and CHU de Reims is published in Clinical Microbiology and Infection. All you want to know 👉urldefense.proofpoint.com/v2/url?u=https…

New preprint from the lab! Thays de Oliveira noticed that activity of the Pseudomonas aeruginosa quorum sensing regulator RhlR is higher at 25°C than at 37°C, and found indications that such a lower temperature promotes its affinity for its C4-HSL ligand biorxiv.org/content/10.110…

We're excited to introduce a revised scope for PLOS Pathogens! Read the scope updates, see details on how we've broadened our article formats for submission, and more in our latest Editorial: plos.io/4cvPdX6.

Today we report in Nature Biomedical Engineering the systematic application of six recent prime editing developments to enable efficient and functional correction of CFTR F508del, the predominant mutation that causes cystic fibrosis (CF), in primary airway cells from CF patients.